Literature DB >> 6933243

American white Protestant clergy as a low-risk population for mortality research.

H King, F B Locke.   

Abstract

An examination of 28,134 clergymen in five predominantly white Protestant denominations, 1950--60, showed a more favorable mortality for these clergymen for all causes of deaths, total cancers, and cardiovascular-renal diseases compared with the mortality for U.S. white males, total U.S. males with work experience, and total U.S. white clergymen. The standardized mortality ratios for cancer of the lung and non-motor-vehicle accidents were particularly depressed. However, those for diabetes, leukemia, and cancers of the prostate gland and, to a lesser extent, lymphoma and cancers of the intestine and pancreas were not significantly different from 100. The findings were interpreted in the social class contest, with emphasis on cross-national investigations and critical assessment of clerical statistics.

Entities:  

Mesh:

Year:  1980        PMID: 6933243

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  Religion, Type A behavior, and health.

Authors:  J S Levin; C D Jenkins; R M Rose
Journal:  J Relig Health       Date:  1988-12

2.  Breast cancer in priests: follow-up of an observation made 167 years ago.

Authors:  Lin Fritschi; Pascal Guenel; Wolfgang Ahrens
Journal:  Eur J Epidemiol       Date:  2010-01-21       Impact factor: 8.082

3.  Cancer incidence among priests: 45 years of follow-up in four Nordic countries.

Authors:  Andreas Stang; Jan Ivar Martinsen; Kristina Kjaerheim; Elisabete Weiderpass; Pär Sparén; Laufey Tryggvadóttir; Eero Pukkala
Journal:  Eur J Epidemiol       Date:  2011-12-27       Impact factor: 8.082

4.  Mortality among Japanese Zen priests.

Authors:  M Ogata; M Ikeda; M Kuratsune
Journal:  J Epidemiol Community Health       Date:  1984-06       Impact factor: 3.710

5.  Risk factors for breast cancer, including occupational exposures.

Authors:  Elisabete Weiderpass; Margrethe Meo; Harri Vainio
Journal:  Saf Health Work       Date:  2011-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.